{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 451555065
| IUPAC_name = (±)-1-(1,3-benzodioxol-5-yl)-2-(ethylamino)butan-1-one
| image = Eutylone.svg
<!--Clinical data-->
| tradename =  
| pregnancy_category =  
| legal_CA = Schedule I
| legal_UK = Class B
| legal_status =  
| routes_of_administration =
<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =
<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 802855-66-9
| CAS_number2_Ref = {{cascite|changed|??}}
| CAS_number2 = 17764-18-0
| index_label =
| index2_label = HCl
| ATC_prefix = none
| ATC_suffix =  
| PubChem = 57360686
| UNII_Ref = {{fdacite|changed|FDA}}
| UNII = D6WQJ7NF96
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 26716427
<!--Chemical data-->
| C=13 | H=17 | N=1 | O=3
| molecular_weight = 235.278 g/mol
| smiles = CCC(C(=O)C1=CC2=C(C=C1)OCO2)NCC
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C13H17NO3/c1-3-10(14-4-2)13(15)9-5-6-11-12(7-9)17-8-16-11/h5-7,10,14H,3-4,8H2,1-2H3
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = YERSNXHEOIYEGX-UHFFFAOYSA-N
}}

'''β-Keto-1,3-benzodioxolyl-''N''-ethylbutanamine''' ('''Eutylone''', '''bk-EBDB''') is a [[stimulant]] compound developed in the 1960s,<ref>Substituted phenyl-α-amino ketones. British Patent {{Cite patent|GB|1085135}} (1969).</ref> which has been reported as a novel [[designer drug]].<ref>{{cite web | url=http://nsddb.eu/substance/413/ | title=Eutylone | publisher=New Synthetic Drugs Database}}</ref>

== References ==
{{Reflist}}

{{Entactogens|state=expanded}}
{{Stimulants}}
{{Phenethylamines}}

[[Category:Cathinones]]
[[Category:Designer drugs]]
[[Category:Benzodioxoles]]
[[Category:Serotonin-norepinephrine-dopamine releasing agents]]
[[Category:Entactogens and empathogens]]